Patient-Derived Xenograft Model Market Size to Reach US$ 1,119.36 Million by 2031
The growing demand for advanced oncology research platforms is transforming preclinical cancer studies worldwide. Researchers are increasingly adopting patient-specific tumor models to improve translational outcomes and accelerate precision medicine initiatives. Continuous innovation in cancer biology, genomic technologies, and personalized therapeutics …